Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.64B |
| 2 |
Microsoft
MSFT
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$1.17B |
| 4 |
Gilead Sciences
GILD
|
+$1.08B |
| 5 |
Eli Lilly
LLY
|
+$996M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.21B |
| 3 |
United Parcel Service
UPS
|
+$1.06B |
| 4 |
T-Mobile US
TMUS
|
+$908M |
| 5 |
McDonald's
MCD
|
+$883M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Financials | 15.98% |
| 3 | Healthcare | 15.38% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Unitil
UTL
$970M
| $1.33M | ﹤0.01% |
25,413
+2,308
| +10% | +$128K |
|
1577
Capricor Therapeutics
CAPR
$223M
| $1.31M | ﹤0.01% |
131,877
+21,146
| +19% | +$223K |
|
1578
Teradyne
TER
$57.6B
| $1.3M | ﹤0.01% |
14,498
+679
| +5% | +$54.3K |
|
|
TRML
1579
DELISTED
Tourmaline Bio
TRML
| $1.3M | ﹤0.01% |
81,076
+6,337
| +8% | +$103K |
|
1580
Atea Pharmaceuticals
AVIR
$376M
| $1.29M | ﹤0.01% |
359,451
+54,921
| +18% | +$164K |
|
1581
Zevra Therapeutics
ZVRA
$562M
| $1.29M | ﹤0.01% |
146,284
+5,866
| +4% | +$47.6K |
|
1582
Futu Holdings
FUTU
$14.7B
| $1.29M | ﹤0.01% |
10,399
+7,888
| +314% | +$807K |
|
1583
Brighthouse Financial
BHF
$3.56B
| $1.27M | ﹤0.01% |
23,633
-9,701
| -29% | -$545K |
|
|
TERN
1584
DELISTED
Terns Pharmaceuticals
TERN
| $1.25M | ﹤0.01% |
335,169
+14,006
| +4% | +$43.7K |
|
1585
NET Power
NPWR
$126M
| $1.22M | ﹤0.01% |
494,349
-18,540
| -4% | -$38.9K |
|
1586
Expedia Group
EXPE
$35.4B
| $1.22M | ﹤0.01% |
7,234
+320
| +5% | +$51.9K |
|
1587
DaVita
DVA
$15.4B
| $1.22M | ﹤0.01% |
8,561
+213
| +3% | +$30.2K |
|
1588
Best Buy
BBY
$18.2B
| $1.21M | ﹤0.01% |
18,033
+6,289
| +54% | +$427K |
|
1589
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
| $1.21M | ﹤0.01% |
6,197
| – | – |
|
|
YALA
1590
Yalla Group
YALA
$818M
| $1.2M | ﹤0.01% |
+177,792
| New | +$1.21M |
|
1591
Rigel Pharmaceuticals
RIGL
$681M
| $1.2M | ﹤0.01% |
63,820
+2,422
| +4% | +$45.9K |
|
1592
Aura Biosciences
AURA
$725M
| $1.19M | ﹤0.01% |
189,485
+50,533
| +36% | +$296K |
|
|
JNPR
1593
DELISTED
Juniper Networks
JNPR
| $1.18M | ﹤0.01% |
29,665
+1,381
| +5% | +$49.5K |
|
1594
Robinhood
HOOD
$77.8B
| $1.18M | ﹤0.01% |
12,572
-3,689
| -23% | -$218K |
|
1595
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $1.14M | ﹤0.01% |
23,012
-1,974
| -8% | -$91.6K |
|
1596
DoubleVerify
DV
$1.73B
| $1.13M | ﹤0.01% |
75,724
-292,864
| -79% | -$4.01M |
|
1597
Erasca
ERAS
$6.3B
| $1.12M | ﹤0.01% |
885,651
+35,504
| +4% | +$47.5K |
|
1598
Avantor
AVTR
$9.32B
| $1.11M | ﹤0.01% |
82,608
+216
| +0.3% | +$2.96K |
|
1599
Albemarle
ALB
$13.9B
| $1.11M | ﹤0.01% |
17,705
-18,962
| -52% | -$1.12M |
|
1600
Emergent Biosolutions
EBS
$373M
| $1.1M | ﹤0.01% |
173,170
+30,204
| +21% | +$173K |
|
Similar funds
Wellington Management Group's Q2 2025 Portfolio in Review
As of Q2 2025, Wellington Management Group held 2,080 positions worth $551B, up 6% from $520B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group's Q2 2025 filing shows 139 new, 795 increased, 834 reduced and 147 closed positions. Its largest new stake was Amrize Ltd: 7,812,891 shares worth $388M. The largest sale was Procter & Gamble, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Wellington Management Group's largest Q2 2025 buy was Amrize Ltd: 7,812,891 shares worth $388M.
- Wellington Management Group added most to Alphabet (Google) Class A in Q2 2025, an estimated $1.64B increase.
- Wellington Management Group's biggest Q2 2025 reduction was Procter & Gamble, cutting an estimated $1.38B.
- Wellington Management Group fully exited iShares Russell 1000 Growth ETF in Q2 2025, selling an estimated $464M.
- Wellington Management Group's ten largest holdings make up 25% of its $551B portfolio in Q2 2025.
- Wellington Management Group opened 139 new positions and closed 147 in Q2 2025.
- Wellington Management Group's portfolio value rose 6% quarter-over-quarter to $551B.
Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.